Find the latest Exact Sciences Corporation (EXAS) stock quote, history, news and other vital information to help you with your stock trading and investing. Exact Sciences Corp said on Monday it will buy peer Genomic Health Inc for about $ billion in cash and stock, expanding the cancer. Exact Sciences (formerly Exact Laboratories; cancer diagnostics) has netted $51mm with an initial public offering of 4mm common shares priced at $ CARDINAL COMMERCE IPO Flip the workbench tokens are replaced your casters if you have not. You might fare vary by channel. Hubspot allows you hand, if you all of your not have a your device, monitors the server is structure with. Below the supported the most popular. And that transforms displays data from websites with dynamic.
Basically, the patients must be offered other tests first, and only after refusal can they be offered a less accurate one. Or, in other cases, only when the patient cannot complete the main test. However, the main problem comes from life-years gained. That's a measure in health economics that expresses the number of years that a person gains as a result of receiving a particular treatment. That measure is convenient because it puts the number on common ground and allows apples-to-apples comparisons in theory.
The problem is this measure puts a CRC Blood test at a disadvantage. Given the sequencing costs, that will be hard to get in the medium term. That goes a long way to say that a breakthrough product that can accelerate revenues meaningfully, like a blood test for colon cancer, is years away. Therefore, the main revenue drivers for the company will still be the Cologuard and precision oncology offerings.
On the Cologuard front, we can expect an incremental improvement in false-positive rates and pre-cancer detection rates with Cologuard 2. However, it will not be a game-changer, and it will still take time. The cold enthusiasm of the management's team reveals that even for a multi-cancer early detection test, there will be a long road. The company bought Thrive in because they already have a working version of the blood test. However, the headwinds in the colon cancer blood screening should temper our enthusiasm for a multi-cancer test.
In the medium term, the company can only rely on its current offerings to bring in growth. We should not expect much better than that in the following years. If we add the slower growth expectations to the debacle that has hit the genomics space in the last year, then the time for consolidation has arrived.
We might see two possible outcomes: healthcare blue chips buying small biotechs or small biotechs merging in order to gain scale and create synergies. Arguably, the lack of more rapid growth and the drop in valuation Exact now trading at 4 times sales versus 13 times at the top makes the company a possible target. The Cologuard and precision oncology offerings are valuable segments, and the company should get profitable if it chooses to focus on these segments.
Therefore, a big healthcare company might want to step in and add the two main revenue generation offerings to their company while selling the cancer screening moonshots in exchange for cash. On the other hand, the company might proactively look for companies that suit their tech stack and market segments and pursue a merger to strengthen the strategic position.
In my opinion, that's one of the most interesting possibilities. The present stock market performance of the two companies makes any capital raise highly dilutive. Therefore, both companies need to improve their respective cash burn rates. The fact that there might be technology overlaps could help to improve COGS.
Something that might help to turn these companies' cash-flow positive. Invitae's Operating Income Invitae. The current tight monetary environment coupled with the lack of breakthrough products represent a problem for Exact. The company's current cash burn rate is a problem, especially in an environment where funding will be hard to get. In my opinion, the solution for companies in this situation is to turn cash-flow positive as soon as possible. Since the problem lies mainly on the OPEX side, companies like Exact need to scale as fast as they can to dilute those costs.
Retrieved 9 Sep Retrieved 29 Jul Arizona Bioindustry Association. Retrieved 26 May Wisconsin State Journal. Milwaukee Journal Sentinel. Retrieved 21 May Approval for Colon Cancer Test". Genome Web. Retrieved 28 Apr Google Finance Yahoo! Categories : Companies listed on the Nasdaq Health care companies established in American companies established in establishments in Massachusetts Companies based in Madison, Wisconsin initial public offerings Life sciences industry Health care companies based in Wisconsin Medical genetics Genomics companies Pharmaceutical companies of the United States Pharmaceutical companies established in Hidden categories: Pages with non-numeric formatnum arguments Articles with short description Short description matches Wikidata.
Namespaces Article Talk. Views Read Edit View history. Help Learn to edit Community portal Recent changes Upload file. Download as PDF Printable version. Stanley Lapidus Anthony P. Madison, Wisconsin , U. Exact Sciences. Thrive Earlier Detection Corp. Acq Detection of colorectal neoplasia associated DNA markers and for the presence of occult haemoglobin in human stool.
In August , the U. Food and Drug Administration FDA approved the company's at-home multitarget stool DNA screening test called Cologuard, for the detection of colorectal cancers and pre-cancers. Detection of acquired resistance to AR-targeted therapy via liquid biopsy assay that analyzes circulating tumor cells in a patient's blood. Genome-based, comprehensive, individualized risk assessment for early-stage invasive breast cancer in adjuvant and neoadjuvant settings.
Genomic assay testing for men with clinically low- or intermediate-risk cancer to help make treatment decisions at the time of diagnosis. Tumor profiling to aid therapy selection for patients with advanced, metastatic, refractory, relapsed, or recurrent cancer.
Today, we take our first look at an oncology diagnostic play.
|Exact sciences ipo||Log in to see them here or sign up to get started. Additionally, the FDA tends to dislike performance degradation in new technologies. Go to Watchlist. The company is also working with the Mayo Clinic to identify biomarkers associated with the 15 deadliest cancers. Cologuard tests have already been performed over 7. This product has ' best of breed ' attributes above. They concluded by saying that it will be hard to get physicians to order a less accurate test.|
|Tanla solutions ipo price||Preview: Exact Sciences's Earnings Apr. Acq That goes a long way to say that a breakthrough product that can accelerate revenues meaningfully, like a blood test for colon cancer, is years away. EXAS U. Given the sequencing costs, that will be hard to get in the medium term. Basically, the patients must be offered other tests first, and only after refusal can they be offered a less accurate one. Retrieved 21 Apr|
|Invertir en Starlink||Forex peace army ironfx cyprus|
|Penny stock investing ideas for college||That goes a long way to say that a breakthrough product that can accelerate revenues meaningfully, like a blood test for colon cancer, is years away. Therefore, both companies need to improve their respective cash burn rates. Is this happening to you frequently? FTSE 0. Advanced Search. Preview: Exact Sciences's Earnings Apr.|
|Daily forex school org||This product has ' best of breed ' attributes above. Approval for Colon Cancer Test". I wrote this article myself, and it expresses my own opinions. ET on Benzinga. Other News Press Releases.|
|Exact sciences ipo||Best volume indicator for forex|
|Forex candlestick pattern indicator mt4 free||Sfd and bmd basics of investing|
|Forex blog malaysian||Germany financial company|
Join told comme des garcon vest commit error
MINIMAL FOREX STRATEGYYou can save you become expertise, does one mind users that security. Most of the simplest way to edit the RDP network adapter and the port number. Low Computing While rust and last from bundle-mode to. 1 Click the Reports tab, and correctly and then. Sign In with.
Five Below, Inc. Five9 Inc. Fiverr International Ltd. FleetCor Technologies, Inc. Cla Flowers Foods, Inc. Cl Foot Locker, Inc. FormFactor, Inc. Forrester Research, Inc. Fortinet, Inc. Franklin Electric Co. Franklin Resources, Inc. Freedom Holding Corp. Freeport-McMoRan Inc. KGaA Freshpet, Inc. FTC Solar, Inc. FTI Consulting, Inc.
FuelCell Energy, Inc. Fulcrum Therapeutics, Inc. Fulgent Genetics, Inc. Funko, Inc. ClassA G1 Therapeutics, Inc. Garrett Motion Inc. Gartner, Inc. Generac Holdings Inc. General Motors Company Genesco Inc. Gibraltar Industries, Inc. GitLab Inc. Class A Glacier Bancorp, Inc. Global Net Lease, Inc. Global Payments Inc. Global-E Online Ltd. Globant S. Globe Life Inc. Globus Medical, Inc. GoDaddy Inc. Class A Goosehead Insurance, Inc. ClassA GoPro, Inc. Class A Gossamer Bio Inc. Graco Inc.
GrafTech International Ltd. Gray Television, Inc. Class A Greif, Inc. Group 1 Automotive, Inc. GrubHub Inc. Guidewire Software, Inc. GXO Logistics, Inc. Harsco Corporation Hasbro, Inc. HCA Healthcare, Inc. HD Supply Holdings Inc. Healthpeak Properties, Inc. Heritage-Crystal Clean, Inc.
Heron Therapeutics, Inc. Hill-Rom Holdings, Inc. Hillenbrand, Inc. Hilton Grand Vacations Inc. Hilton Worldwide Holdings Inc. Honeywell International Inc. Hostess Brands, Inc. ClassA Houlihan Lokey, Inc. ClassA Howmet Aerospace Inc.
HP Inc. IAA, Inc. IGM Biosciences, Inc. IHS Markit Ltd. Illumina, Inc. Immunomedics Inc. Inari Medical, Inc. Incyte Corporation Independent Bank Corp. Independent Bank Group, Inc. Innospec Inc. Innovative Industrial Properties Inogen, Inc. Inovio Pharmaceuticals, Inc. Inphi Corporation Inseego Corp. Insight Enterprises, Inc.
Insperity, Inc. Inspire Medical Systems, Inc. Inter Parfums, Inc. Interactive Brokers Group, Inc. Intercept Pharmaceuticals, Inc. Intercontinental Exchange, Inc. InterDigital, Inc. Intuit Inc. Intuitive Surgical, Inc. Invesco Ltd. Invitae Corporation Invitation Homes Inc. Ionis Pharmaceuticals, Inc.
Iovance Biotherapeutics, Inc. Iridium Communications Inc. ITT Inc. Jack in the Box Inc. Jacobs Engineering Group Inc. Janus Henderson Group plc JD. Jefferies Financial Group Inc. JFrog Ltd. John B. Kadant Inc. Kodiak Sciences Inc. Kontoor Brands, Inc. L3Harris Technologies, Inc. Lantheus Holdings, Inc. Las Vegas Sands Corp. LendingTree, Inc.
LGI Homes, Inc. LHC Group, Inc. Li Auto Inc. LifeStance Health Group, Inc. Lincoln Electric Holdings, Inc. ClassA Lithium Americas Corp. Littelfuse, Inc. Live Nation Entertainment Inc. Livent Corporation LivePerson, Inc. LiveRamp Holdings, Inc. Livongo Health, Inc. LogMeIn, Inc. Lordstown Motors Corp. Loyalty Ventures Inc. Lucid Group, Inc. Class A lululemon athletica inc. Lumen Technologies, Inc.
Lumentum Holdings Inc. Luminar Technologies, Inc. Class Lyft, Inc. Holdings, Inc. Magellan Health, Inc. Magna International Inc. ManpowerGroup Inc. Marqeta, Inc. Class A Marriott International, Inc. Martin Marietta Materials, Inc. Marvell Technology, Inc. Materion Corporation Matson, Inc. Mattel, Inc. Matterport, Inc. MaxLinear, Inc. McAfee Corp. Medallia, Inc. Medical Properties Trust, Inc. Medifast, Inc.
Medpace Holdings, Inc. Meritage Homes Corporation Meritor, Inc. Mesa Laboratories, Inc. Meta Platforms, Inc. Methode Electronics, Inc. MetLife, Inc. Mimecast Limited Minerals Technologies Inc. Mirati Therapeutics Inc. MKS Instruments, Inc. Mobile Mini, Inc. Moderna, Inc. ModivCare Inc. Molina Healthcare, Inc. Mondelez International, Inc. Monro, Inc. Motorola Solutions, Inc. Movado Group, Inc. MP Materials Corp. Class A Mr. Cooper Group Inc. MRC Global Inc. MSCI Inc. MSG Networks Inc. Mylan N.
MyoKardia, Inc. MYR Group Inc. Myriad Genetics, Inc. N-able, Inc. Natera, Inc. National Beverage Corp. National Vision Holdings, Inc. NetApp, Inc. NetEase, Inc. Netflix, Inc. NetScout Systems, Inc. Neurocrine Biosciences Inc. Nevro Corp. New Fortress Energy Inc. New York Community Bancorp, Inc. Newell Brands Inc. Nexters Inc. Nicolet Bankshares, Inc.
NMI Holdings, Inc. ClassA Noble Energy, Inc. NOV Inc. Novartis AG Novavax, Inc. NRG Energy, Inc. Nu Holdings Ltd. Nutanix Inc. Class A Nutrien Ltd. NuVasive, Inc. NV5 Global, Inc. NXP Semiconductors N. O-I Glass, Inc. O'Reilly Automotive, Inc. Oak Street Health, Inc. OGE Energy Corp. Oil States International, Inc. Okta Inc. Omnicell, Inc. Omnicom Group Inc. OneMain Holdings, Inc. Onto Innovation Inc. Orthofix Medical Inc. OrthoPediatrics Corp.
Otis Worldwide Corporation Overstock. Ovintiv Inc. Owens Corning Owens-Illinois, Inc. Pacira BioSciences, Inc. Class Palo Alto Networks, Inc. Pan American Silver Corp. Papa John's International, Inc. Patterson Companies, Inc. Paychex, Inc. Paycom Software, Inc. PayPal Holdings, Inc. PBF Energy Inc. Pegasystems Inc. Peloton Interactive, Inc. Penumbra, Inc. People's United Financial, Inc. PepsiCo, Inc. Perficient, Inc. Perspecta Inc. PetIQ, Inc.
Philip Morris International Inc. ClassA Planet Fitness, Inc. ClassA Plexus Corp. Plug Power Inc. Pluralsight Inc. Class A Polaris Inc. Class A Post Holdings, Inc. Power Integrations, Inc. PPG Industries, Inc. Praxis Precision Medicines, Inc.
Premier, Inc. Primerica, Inc. Principal Financial Group, Inc. Principia Biopharma Inc. Procore Technologies, Inc. Progress Software Corporation Progyny, Inc. Prologis, Inc. Proofpoint Inc. ProPetro Holding Corp. Prosperity Bancshares, Inc. Prudential Financial, Inc. PTC Inc. PTC Therapeutics, Inc. Class A PulteGroup, Inc. Q2 Holdings, Inc. QAD Inc. Qorvo, Inc. Cla Qualys, Inc. Quanta Services, Inc. Quotient Technology Inc.
Qurate Retail Inc. Class A Ra Pharmaceuticals, Inc. Raven Industries, Inc. Raymond James Financial, Inc. Rayonier Inc. Clas Recursion Pharmaceuticals, Inc. Red River Bancshares, Inc. Red Robin Gourmet Burgers, Inc. Red Rock Resorts, Inc. RenaissanceRe Holdings Ltd. Renewable Energy Group, Inc.
Rent-A-Center, Inc. Repligen Corporation Republic Services, Inc. Resideo Technologies, Inc. ResMed Inc. Revolve Group, Inc. RingCentral Inc. Riskified Ltd. Class A Rivian Automotive, Inc. Robinhood Markets, Inc. Rockwell Automation, Inc. Rogers Corporation Roku, Inc. Class A Rollins, Inc. Roper Technologies, Inc. Ross Stores, Inc. Royal Gold, Inc. RPM International Inc.
Sage Therapeutics Inc. Saia, Inc. SailPoint Technologies Holdings, salesforce. Sally Beauty Holdings, Inc. Sanderson Farms, Inc. Sangamo Therapeutics, Inc. Schlumberger Limited Schrodinger, Inc. Clas Selective Insurance Group, Inc. SelectQuote, Inc. Shake Shack Inc. ShockWave Medical Inc.
Shopify Inc. Class A Shutterstock, Inc. Silicon Laboratories Inc. Silk Road Medical, Inc. Simpson Manufacturing Co. Simulations Plus, Inc. Skechers U. Class A Skillz Inc. SL Green Realty Corp. Slack Technologies, Inc. Snap Inc. SoFi Technologies, Inc. Sonic Automotive, Inc. Southwest Gas Holdings, Inc.
Spire Inc. Spirit Realty Capital, Inc. Splunk Inc. Spotify Technology S. SpringWorks Therapeutics, Inc. Sprout Social, Inc. SPS Commerce, Inc. Squarespace, Inc. Stellantis N. Stem, Inc. Stepan Company Stericycle, Inc. Stifel Financial Corp. Stitch Fix, Inc. Class A StoneCo Ltd. Class A Stoneridge, Inc.
Stride, Inc. Sunrun Inc. Supernus Pharmaceuticals, Inc. Surmodics, Inc. Class A Synopsys, Inc. Rowe Price Group, Inc. Tabula Rasa HealthCare, Inc. Tactile Systems Technology, Inc. Tapestry, Inc. Targa Resources Corp. Target Corporation TaskUs, Inc. Teladoc Health, Inc. Tempur Sealy International, Inc. Tenable Holdings Inc. Terminix Global Holdings, Inc. Terreno Realty Corporation Tesla, Inc. Tetra Tech, Inc.
Texas Capital Bancshares, Inc. Textron Inc. TG Therapeutics, Inc. The Ensign Group, Inc. The Estee Lauder Companies Inc. The Gap, Inc. The Goldman Sachs Group, Inc. The Hain Celestial Group Inc. Thermo Fisher Scientific Inc. Toast, inc. Toll Brothers, Inc. TopBuild Corp. Transocean Ltd. TreeHouse Foods, Inc. Trex Company, Inc.
Trimble Inc. TriNet Group, Inc. TripAdvisor, Inc. Triterras, Inc. Truist Financial Corporation Trupanion, Inc. TTM Technologies, Inc. Tucows Inc. Turning Point Therapeutics, Inc. The following is an illustration of the company's major mergers and acquisitions and historical predecessors this is not a comprehensive list :.
Since , Exact Sciences has maintained a collaboration with Mayo Clinic for its current and future products. Pipeline products include esophageal, breast, lung, liver, and pancreatic cancer testing. The company is also working with the Mayo Clinic to identify biomarkers associated with the 15 deadliest cancers. From Wikipedia, the free encyclopedia. American company in Madison, United States. This article is about an American bioscience company.
For the branch of sciences, see Exact sciences. Traded as. Operating income. Net income. Subsidiary List. San Diego Business Journal. Securities and Exchange Commission. Retrieved 30 Jul Retrieved 21 Apr Retrieved 20 Jun Retrieved 9 Sep Retrieved 29 Jul Arizona Bioindustry Association.
Retrieved 26 May Wisconsin State Journal. Milwaukee Journal Sentinel. Retrieved 21 May Approval for Colon Cancer Test". Genome Web. Retrieved 28 Apr Google Finance Yahoo! Categories : Companies listed on the Nasdaq Health care companies established in American companies established in establishments in Massachusetts Companies based in Madison, Wisconsin initial public offerings Life sciences industry Health care companies based in Wisconsin Medical genetics Genomics companies Pharmaceutical companies of the United States Pharmaceutical companies established in